Objective:

To address the underrepresentation of Black and Hispanic or Latino populations in clinical trials and promote strategies for inclusion, highlighting the importance of diversity for improving health outcomes.

Key Findings:

• Black and Hispanic populations are underrepresented in clinical trials despite higher disease prevalence, which can lead to disparities in treatment efficacy.
• Mistrust in the healthcare system, rooted in historical mistreatment, contributes to this underrepresentation, affecting health outcomes.
• Community-based approaches can significantly increase enrollment of diverse populations, thereby improving the relevance of clinical research.

Interpretation:

Building trust through community engagement and addressing misconceptions can enhance diversity in clinical research, ultimately improving health equity and patient outcomes.

Limitations:

• Historical mistrust may not be easily overcome, requiring tailored communication strategies.
• Community engagement requires sustained effort and resources, including funding and partnerships with local organizations.

Conclusion:

Enhancing diversity in clinical trials is essential for equitable health outcomes, and community-based strategies can effectively bridge the gap, leading to better health for all.